0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Effect of Tamoxifen on von Willebrand Factor Levels

Nadra Ounnoughène, MD; Pascale Molho, MD; Natalie Stieltjes, MD; Yvette Sultan, PhD
Arch Intern Med. 1997;157(14):1613. doi:10.1001/archinte.1997.00440350127014.
Text Size: A A A
Published online

We read with great interest the article by Mannucci et al1 entitled "Effect of Tamoxifen on Measurements of Hemostasis in Healthy Women."

We report the case of a 61-year-old woman, with blood type O, Rh positive, and von Willebrand disease (vWD) type I, who was treated with tamoxifen for breast cancer. In this case, the tamoxifen use normalized the abnormal hemostatic factors related to vWD.

The patient was diagnosed as having vWD in 1991. Although the biological data (Table) showed a mild form of type I with normal bleeding time, 40 U/dL of von Willebrand factor (vWF) ristocetin cofactor, and 49 U/dL of factor VIII activity, the propositus was affected with a lifelong history of bleeding disorder. She experienced bleeding episodes after dental extractions, menorrhagia, post-partum hemorrhages, and in 1976, a hysterectomy was performed for menorrhagia. The mother of the propositus received blood transfusions after delivery. The patient's daughter is

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();